Rare diseases
Investigational molecules
Locations
Evaluation of Optimized Ceftazidime Dosing Regimen Versus Standard Treatment for Critical Care Patients with Sepsis
FranceStudy on the Safety and Effectiveness of Domvanalimab and Zimberelimab for Adults with Advanced Rare Cancers Resistant to Standard Treatment
FranceStudy on the Safety and Effects of YTB323 and Drug Combination in Patients with Progressive Multiple Sclerosis
FranceStudy of Nivolumab and Ipilimumab or Drug Combination for Patients with Metastatic Kidney Cancer
FranceStudy on the Safety and Effects of YTB323, Tocilizumab, and Cyclophosphamide in Patients with Relapsing Multiple Sclerosis Who Have Active Disease Despite Treatment
FranceStudy of Levosimendan Before Tricuspid Valve Surgery in Patients with Right Ventricular Dysfunction
FranceStudy comparing rapcabtagene autoleucel and rituximab in patients with severe refractory diffuse cutaneous systemic sclerosis
FranceStudy of ixazomib, iberdomide and dexamethasone combination in elderly patients with first relapse of multiple myeloma
FranceStudy on Multiple Myeloma Treatment with Isatuximab, Lenalidomide, and Carfilzomib for Patients Under 66 Eligible for Stem Cell Transplant
FranceStudy Comparing Chemotherapy Alone to Dostarlimab, Paclitaxel, and Carboplatin for Patients with Advanced or Metastatic Endometrial Cancer
FranceStudy on the Effectiveness of Carboplatin and Paclitaxel in Treating Cervical Cancer with Para-aortic Lymph Node Involvement
FranceStudy of INCB099280 for Patients With Advanced Cutaneous Squamous Cell Carcinoma Not Suitable for Surgery or Radiotherapy
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
